Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2400
-0.0089 (-3.58%)
At close: Jul 16, 2026, 4:00 PM EDT
0.2419
+0.0019 (0.79%)
Pre-market: Jul 17, 2026, 7:43 AM EDT
Vistagen Therapeutics Employees
Vistagen Therapeutics had 41 employees as of March 31, 2026. The number of employees decreased by 16 or -28.07% compared to the previous year.
Employees
41
Change
-16
Growth
-28.07%
Revenue / Employee
$30,951
Profits / Employee
-$1,699,634
Market Cap
9.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Curis | 24 |
| BioCardia | 21 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| BioRestorative Therapies | 14 |
| Kiora Pharmaceuticals | 13 |
| MetaVia | 8 |
| Immuron | 7 |
VTGN News
- 16 days ago - Vistagen Therapeutics Transcript: Study update - Transcripts
- 16 days ago - Vistagen Therapeutics Press release: Study update - Filings
- 17 days ago - Vistagen announces fasedienol did not achieve primary endpoint - TheFly
- 17 days ago - Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder - Business Wire
- 4 weeks ago - Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - Business Wire
- 4 weeks ago - Vistagen Therapeutics Earnings release: Q4 2026 - Filings
- 4 weeks ago - Vistagen Therapeutics Annual report: Q4 2026 - Filings
- 5 weeks ago - Vistagen announces fasedienol achieves minimum patient exposures - TheFly